Cambridge, MA – January 30, 2006– Biogen Idec (NASDAQ: BIIB) announced today that Susan H. Alexander has been appointed Executive Vice President, General Counsel and Corporate Secretary. She reports to James C. Mullen, Chief Executive Officer of Biogen Idec.
“With more than 20 years of legal experience and in-depth knowledge of life science, high-tech and chemical manufacturing industries, European legal issues and mergers and acquisitions activity, Susan will be a valued leader as we continue to execute on our plan for long-term growth,” said Mullen.
Alexander joins Biogen Idec from PAREXEL International, a global leader in assisting pharmaceutical, biotechnology and medical device companies bringing new products to market, where she served as Senior Vice President, General Counsel and Corporate Secretary. From 1995 to 2003, she was the General Counsel and Secretary at IONA Technologies and Counsel at Cabot Corporation. In addition, Alexander previously served as a partner at the law firms of Hinckley, Allen & Snyder and Fine & Ambrogne.
About Biogen Idec
Biogen Idec creates new standards of care in oncology, neurology and immunology. As a global leader in the development, manufacturing and commercialization of novel therapies, Biogen Idec transforms scientific discoveries into advances in human healthcare. For product labelling, press releases and additional information about the company, please visit www.biogenidec.com .
For more information contact:
Associate Director, Public Affairs
Investment Community Contact:
Senior Manager, Investor Relations